Published in Transfusion on July 01, 2002
The natural history of hepatitis C virus (HCV) infection. Int J Med Sci (2006) 3.13
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol (2005) 1.24
Three-dimensional array-based group testing algorithms. Biometrics (2008) 1.18
Blood screening for influenza. Emerg Infect Dis (2007) 1.07
Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR. J Clin Microbiol (2012) 0.99
Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus (2011) 0.95
High throughput screening for spores and vegetative forms of pathogenic B. anthracis by an internally controlled real-time PCR assay with automated DNA preparation. Med Microbiol Immunol (2006) 0.89
Quarantine Plasma: Quo vadis? Transfus Med Hemother (2010) 0.87
Autologous blood in obstetrics: where are we going now? Blood Transfus (2011) 0.87
Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World J Gastroenterol (2014) 0.87
A general change of the platelet transfusion policy from apheresis platelet concentrates to pooled platelet concentrates is associated with a sharp increase in donor exposure and infection rates. Transfus Med Hemother (2008) 0.85
Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India. Asian J Transfus Sci (2014) 0.79
Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital. J Virol Methods (2011) 0.77
Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences. Transfus Med Hemother (2008) 0.75
10 Autologous Hemotherapy. Transfus Med Hemother (2009) 0.75
Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples. Transfusion (2005) 0.75
HCV NAT in Austria. Transfusion (2003) 0.75
New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology. ScientificWorldJournal (2013) 0.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature (2004) 5.95
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis (2014) 3.74
Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis (2013) 3.61
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg Infect Dis (2008) 3.00
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86
Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis (2010) 2.65
Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis (2009) 2.52
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood (2006) 2.49
Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerg Infect Dis (2008) 2.35
Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis (2008) 2.29
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion (2008) 2.27
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19
Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17
Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism. Transfusion (2005) 2.13
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems. Transfusion (2013) 2.10
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Henipavirus RNA in African bats. PLoS One (2009) 2.10
High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health (2015) 2.09
Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis (2013) 2.06
Amplification of emerging viruses in a bat colony. Emerg Infect Dis (2011) 1.98
Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis (2007) 1.93
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis (2014) 1.89
Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89
Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. J Clin Microbiol (2007) 1.79
Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis (2007) 1.75
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis (2014) 1.71
Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol (2012) 1.69
Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64
Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63
Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62
Hantavirus in bat, Sierra Leone. Emerg Infect Dis (2012) 1.60
Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit. Cytotherapy (2010) 1.57
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost (2005) 1.55
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Sustained expansion and transgene expression of coagulation factor VIII-transduced cord blood-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2003) 1.50
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion (2010) 1.49
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion (2004) 1.49
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice. Blood (2011) 1.48
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44
Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerg Infect Dis (2014) 1.42
Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis (2010) 1.40
Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol (2013) 1.40
Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol (2007) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
Novel human parechovirus from Brazil. Emerg Infect Dis (2009) 1.36
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis (2006) 1.35
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol (2004) 1.33
Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol (2010) 1.31
Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med (2014) 1.30
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis (2005) 1.28
Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol (2003) 1.28
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion (2007) 1.27
Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs. J Virol (2013) 1.26
Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods (2008) 1.26
Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum. PLoS One (2011) 1.23
An insect nidovirus emerging from a primary tropical rainforest. MBio (2011) 1.23
Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells (2007) 1.22
Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis (2007) 1.20
Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci U S A (2013) 1.19
Two novel parvoviruses in frugivorous New and Old World bats. PLoS One (2011) 1.19
Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCR. Med Microbiol Immunol (2003) 1.17
Treatment of patients with advanced cancer with the natural killer cell line NK-92. Cytotherapy (2013) 1.17
Discovery of a unique novel clade of mosquito-associated bunyaviruses. J Virol (2013) 1.17
In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med (2007) 1.16
Virus discovery and recent insights into virus diversity in arthropods. Curr Opin Microbiol (2013) 1.16
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol (2005) 1.15
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog (2011) 1.14
Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs. Am J Respir Crit Care Med (2013) 1.14
Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis (2014) 1.13
Novel serotypes 105 and 116 are members of distinct subgroups of human enterovirus C. J Gen Virol (2012) 1.13
Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity. Transfusion (2009) 1.13
Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J Virol (2012) 1.12
Rapid detection and differentiation of human pathogenic orthopox viruses by a fluorescence resonance energy transfer real-time PCR assay. Clin Chem (2004) 1.11
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol (2015) 1.11